![Researcher Radio artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts123/v4/ec/a3/1b/eca31b05-4f70-907f-1bfe-a5d5fd52cc4c/mza_4703747951352749034.jpeg/100x100bb.jpg)
Prof Alessandro Lagana - Multiple myeloma treatment
Researcher Radio
English - August 10, 2022 09:32 - 9 minutes - 21.6 MB - ★★★★★ - 3 ratingsEducation Science science academia technology psychology biology chemistry social media publishing journals research Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Nanotechnology - Moving research from the lab bench to the market shelf
This content is part of the Research in Practice in Cancer series of interviews with scientists, focusing on how their research work can have impact on medical practice. Click here to follow Research in Practice in Cancer - for free - on Researcher for more great interviews.
You can read and discover Prof. Alessandro Lagana’s research here.
A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma is published in American Society of Clinical Oncology
Hosted on Acast. See acast.com/privacy for more information.